Barbash GI - Search Results

1

Significance of diabetes mellitus in patients with acute myocardial infarction receiving thrombolytic therapy. Investigators of the International Tissue Plasminogen Activator/Streptokinase Mortality Trial.

Barbash GI, White HD, Modan M, Van de Werf F. Barbash GI, et al. J Am Coll Cardiol. 1993 Sep;22(3):707-13. doi: 10.1016/0735-1097(93)90180-9. J Am Coll Cardiol. 1993. PMID: 8354802 Free article. Clinical Trial.

2

Antecedent angina pectoris predicts worse outcome after myocardial infarction in patients receiving thrombolytic therapy: experience gleaned from the International Tissue Plasminogen Activator/Streptokinase Mortality Trial.

Barbash GI, White HD, Modan M, Van de Werf F. Barbash GI, et al. J Am Coll Cardiol. 1992 Jul;20(1):36-41. doi: 10.1016/0735-1097(92)90134-9. J Am Coll Cardiol. 1992. PMID: 1607536 Free article. Clinical Trial.

3

Should thrombolytic therapy be administered in the mobile intensive care unit in patients with evolving myocardial infarction? A pilot study.

Roth A, Barbash GI, Hod H, Miller HI, Rath S, Modan M, Har-Zahav Y, Keren G, Bassan S, Kaplinsky E, et al. Roth A, et al. Among authors: barbash gi. J Am Coll Cardiol. 1990 Apr;15(5):932-6. doi: 10.1016/0735-1097(90)90219-f. J Am Coll Cardiol. 1990. PMID: 2107239 Free article. Clinical Trial.

4

Improved survival but not left ventricular function with early and prehospital treatment with tissue plasminogen activator in acute myocardial infarction.

Barbash GI, Roth A, Hod H, Miller HI, Modan M, Rath S, Zahav YH, Shachar A, Basan S, Battler A, et al. Barbash GI, et al. Am J Cardiol. 1990 Aug 1;66(3):261-6. doi: 10.1016/0002-9149(90)90832-l. Am J Cardiol. 1990. PMID: 2114782 Clinical Trial.

5

Randomized controlled trial of late in-hospital angiography and angioplasty versus conservative management after treatment with recombinant tissue-type plasminogen activator in acute myocardial infarction.

Barbash GI, Roth A, Hod H, Modan M, Miller HI, Rath S, Zahav YH, Keren G, Motro M, Shachar A, et al. Barbash GI, et al. Am J Cardiol. 1990 Sep 1;66(5):538-45. doi: 10.1016/0002-9149(90)90478-j. Am J Cardiol. 1990. PMID: 2118299 Clinical Trial.

6

Rapid resolution of ST elevation and prediction of clinical outcome in patients undergoing thrombolysis with alteplase (recombinant tissue-type plasminogen activator): results of the Israeli Study of Early Intervention in Myocardial Infarction.

Barbash GI, Roth A, Hod H, Miller HI, Rath S, Har-Zahav Y, Modan M, Seligsohn U, Battler A, Kaplinsky E, et al. Barbash GI, et al. Br Heart J. 1990 Oct;64(4):241-7. doi: 10.1136/hrt.64.4.241. Br Heart J. 1990. PMID: 2121199 Free PMC article. Clinical Trial.

7

Intermittent, dose-related fluctuations of pain and ST elevation during infusion of recombinant tissue plasminogen activator during acute myocardial infarction.

Barbash GI, Hod H, Rath S, Miller HI, Roth A, Har-Zahav Y, Modan M, Rotstein Z, Batler A, Zivelin A, et al. Barbash GI, et al. Am J Cardiol. 1989 Jul 15;64(3):225-8. doi: 10.1016/0002-9149(89)90463-3. Am J Cardiol. 1989. PMID: 2500841 No abstract available.

8

Correlation of baseline plasminogen activator inhibitor activity with patency of the infarct artery after thrombolytic therapy in acute myocardial infarction.

Barbash GI, Hod H, Roth A, Miller HI, Rath S, Zahav YH, Modan M, Zivelin A, Laniado S, Seligsohn U. Barbash GI, et al. Am J Cardiol. 1989 Dec 1;64(19):1231-5. doi: 10.1016/0002-9149(89)90559-6. Am J Cardiol. 1989. PMID: 2511742

9

Evaluation of paradoxic beneficial effects of smoking in patients receiving thrombolytic therapy for acute myocardial infarction: mechanism of the "smoker's paradox" from the GUSTO-I trial, with angiographic insights. Global Utilization of Streptokinase and Tissue-Plasminogen Activator for Occluded Coronary Arteries.

Barbash GI, Reiner J, White HD, Wilcox RG, Armstrong PW, Sadowski Z, Morris D, Aylward P, Woodlief LH, Topol EJ. Barbash GI, et al. J Am Coll Cardiol. 1995 Nov 1;26(5):1222-9. doi: 10.1016/0735-1097(95)00299-5. J Am Coll Cardiol. 1995. PMID: 7594035 Free article. Clinical Trial.

10

Acute myocardial infarction in the young--the role of smoking. The Investigators of the International Tissue Plasminogen Activator/Streptokinase Mortality Trial.

Barbash GI, White HD, Modan M, Diaz R, Hampton JR, Heikkila J, Kristinsson A, Moulopoulos S, Paolasso EA, Van der Werf T, et al. Barbash GI, et al. Eur Heart J. 1995 Mar;16(3):313-6. Eur Heart J. 1995. PMID: 7789372 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

74 results

Search Page

Filters